HFM
GSK icon

Harvest Fund Management’s GSK GSK Stock Holding History

Harvest Fund Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-169
Closed -$6K – 708
2023
Q1 		$6K Hold
169
– – ﹤0.01% 678
2022
Q4 		$6K Sell
169
-236
-58% -$7.86K ﹤0.01% 693
2022
Q3 		$12K Buy
+405
New +$15.3K ﹤0.01% 625

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harvest Fund Management's GSK Position: Q2 2023 in Review

Harvest Fund Management sold out of GSK (GSK) in Q2 2023, closing a stake of 169 shares — an estimated $6K sold.

Harvest Fund Management first reported a position in GSK in Q3 2022 and held it in 3 quarters. The position peaked at $12K in Q3 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • Harvest Fund Management reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • Harvest Fund Management sold 169 GSK shares in Q2 2023, an estimated $6K.
  • Harvest Fund Management first reported a position in GSK in Q3 2022 and held it in 3 quarters.
  • Harvest Fund Management's GSK position peaked at $12K in Q3 2022.
  • 827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Harvest Fund Management's 13F filing for Q2 2023, filed 7 Jul 2023.